Center-Authored Papers

Filters: Author is Skapek, Stephen X  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Arnold MA, Anderson JR, Gastier-Foster JM, Barr FG, Skapek SX, Hawkins DS, Raney BR, Parham DM, Teot LA, Rudzinski ER et al..  2016.  Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group.. Pediatric blood & cancer. Abstract
C
Chen L, Shern JF, Wei JS, Yohe ME, Song YK, Hurd L, Liao H, Catchpoole D, Skapek SX, Barr FG et al..  2015.  Clonality and evolutionary history of rhabdomyosarcoma.. PLoS genetics. 11(3):e1005075. Abstract
H
Hingorani P, Janeway K, Crompton BD, Kadoch C, Mackall CL, Khan J, Shern JF, Schiffman J, Mirabello L, Savage SA et al..  2016.  Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.. Cancer genetics. Abstract
Hingorani P, Missiaglia E, Shipley J, Anderson JR, Triche TJ, Delorenzi M, Gastier-Foster J, Wing M, Hawkins DS, Skapek SX.  2015.  Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group.. Clinical cancer research : an official journal of the American Association for Cancer Research. 21(20):4733-9. Abstract
L
Lupo PJ, Danysh HE, Plon SE, Curtin K, Malkin D, Hettmer S, Hawkins DS, Skapek SX, Spector LG, Papworth K et al..  2015.  Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database.. Cancer medicine. 4(5):781-90. Abstract
Lupo PJ, Danysh HE, Skapek SX, Hawkins DS, Spector LG, Zhou R, Okcu FM, Papworth K, Erhardt EB, Grufferman S.  2014.  Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children's Oncology Group.. Cancer causes & control : CCC. 25(7):905-13. Abstract
Lupo PJ, Zhou R, Skapek SX, Hawkins DS, Spector LG, Scheurer ME, Fatih Okcu M, Melin B, Papworth K, Erhardt EB et al..  2014.  Allergies, atopy, immune-related factors and childhood rhabdomyosarcoma: A report from the children's oncology group.. International journal of cancer. Journal international du cancer. 134(2):431-6. Abstract
R
Rudzinski ER, Teot LA, Anderson JR, Moore J, Bridge JA, Barr FG, Gastier-Foster JM, Skapek SX, Hawkins DS, Parham DM.  2013.  Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.. American journal of clinical pathology. 140(1):82-90. Abstract
Rudzinski ER, Anderson JR, Lyden ER, Bridge JA, Barr FG, Gastier-Foster JM, Bachmeyer K, Skapek SX, Hawkins DS, Teot LA et al..  2014.  Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group.. The American journal of surgical pathology. 38(5):654-9. Abstract
S
Sankaran H, Danysh HE, Scheurer ME, Okcu FM, Skapek SX, Hawkins DS, Spector LG, Erhardt EB, Grufferman S, Lupo PJ.  2016.  The Role of Childhood Infections and Immunizations on Childhood Rhabdomyosarcoma: A Report From the Children's Oncology Group.. Pediatric blood & cancer. Abstract
Shern JF, Chen L, Chmielecki J, Wei JS, Patidar R, Rosenberg M, Ambrogio L, Auclair D, Wang J, Song YK et al..  2014.  Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.. Cancer discovery. 4(2):216-31. Abstract
Skapek SX, Anderson J, Barr FG, Bridge JA, Gastier-Foster JM, Parham DM, Rudzinski ER, Triche T, Hawkins DS.  2013.  PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report.. Pediatric blood & cancer. 60(9):1411-7. Abstract
Skapek SX, Anderson JR, Hill AD, Henry D, Spunt SL, Meyer W, Kao S, Hoffer FA, Grier HE, Hawkins DS et al..  2013.  Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study.. Pediatric blood & cancer. 60(7):1108-12. Abstract
X
Xu L, Wilson RA, Laetsch TW, Oliver D, Spunt SL, Hawkins DS, Skapek SX.  2016.  Potential pitfalls of mass spectrometry to uncover mutations in childhood soft tissue sarcoma: A report from the Children's Oncology Group.. Scientific reports. 6:33429. Abstract